New Pediatric Labeling Information Database - Detail

Please note: JavaScript must be enabled for this application to work properly.
Check your settings if you are unsure
if your JavaScript is enabled.

Pediatric Labeling Date:

01/17/2008

Trade Name:

TamiFlu

Generic Name or Proper Name (*):

oseltamivir

Indications Studied:

Safety information resulting from studies that established treatment of uncomplicated acute illness due to influenza infection in patients 1 year and older

Label Changes Summary:

* Influenza can be associated with a variety of neurologic and behavioral symptoms which can include events such as hallucinations, delirium, and abnormal behavior, in some cases resulting in fatal outcomes. These events may occur in the setting of encephalitis or encephalopathy but can occur without obvious severe disease. * These events have been reported in patients receiving oseltamivir, primarily among pediatric patients, appear to be uncommon, and often had an abrupt onset and rapid resolution * If neuropsychiatric symptoms occur, the risks and benefits of continuing treatment should be evaluated for each patient